Kojc Nika, Aleš Rigler Andreja, Mlinšek Gregor, Kovač Damjan, Ferluga Dušan, Arnol Miha
Clin Nephrol. 2017;88(13):109-114. doi: 10.5414/CNP88FX24.
Reduction of immunosuppression is a common therapeutic strategy in patients with polyomavirus nephropathy (PVN) but may be associated with acute rejection. This study aimed to evaluate the morphology of PVN in renal biopsies after reduction of immunosuppression.
Eight of 241 patients who received a kidney transplant between January 2012 and December 2015 presented with BK viremia and biopsy-proven PVN. Morphological evaluation according to Banff criteria and correlation with viremia and kidney function after immunosuppression reduction was performed.
PVN grades A and B were diagnosed on average 4.7 months post-transplant in 1 and 7 patients, respectively. Indication biopsies after immunosuppression reduction showed an increase in tubulitis and interstitial inflammation score compared to those at the time of the PVN diagnosis. Surveillance biopsies 1 year after transplantation revealed resolution of interstitial inflammation and tubulitis accompanied by clearance of BK viremia in 4 patients (50%), including 1 patient with rejection. One patient showed residual interstitial inflammation after viral clearance. In these patients, renal function returned to baseline. One patient with persisting low BK virus (BKV) in serum and kidney showed a decrease of tubulointerstitial inflammation but scarring was seen. Rejection occurred in 3 patients (38%).
CONCLUSION: PVN-associated interstitial inflammation and tubulitis cannot be differentiated morphologically from T-cell-mediated tubulointerstitial rejection. Significant interstitial inflammation and tubulitis in PVN under low-dose immunosuppression might represent immune reconstitution injury, which is reduced after successful BKV clearance from the serum and kidney. Concomitant rejection in PVN patients on low immunosuppression might be efficiently treated with transient pulse immunosuppressive therapy. .
降低免疫抑制是多瘤病毒肾病(PVN)患者常见的治疗策略,但可能与急性排斥反应相关。本研究旨在评估免疫抑制降低后肾活检中PVN的形态学。
2012年1月至2015年12月期间接受肾移植的241例患者中有8例出现BK病毒血症且经活检证实为PVN。根据Banff标准进行形态学评估,并分析免疫抑制降低后与病毒血症和肾功能的相关性。
PVN A级和B级分别在移植后平均4.7个月诊断出,其中1例为A级,7例为B级。免疫抑制降低后的指征性活检显示,与PVN诊断时相比,肾小管炎和间质炎症评分增加。移植后1年的监测活检显示,4例患者(50%)的间质炎症和肾小管炎消退,同时BK病毒血症清除,其中1例患者发生排斥反应。1例患者在病毒清除后仍有残余间质炎症。在这些患者中,肾功能恢复至基线水平。1例血清和肾脏中BK病毒(BKV)持续低水平的患者,肾小管间质炎症减轻,但出现了瘢痕形成。3例患者(38%)发生排斥反应。
PVN相关的间质炎症和肾小管炎在形态学上无法与T细胞介导的肾小管间质排斥反应相鉴别。低剂量免疫抑制下PVN中显著的间质炎症和肾小管炎可能代表免疫重建损伤,血清和肾脏中BKV成功清除后这种损伤会减轻。PVN患者在低免疫抑制状态下并发的排斥反应可通过短暂的脉冲免疫抑制治疗有效治疗。